Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 8—August 2002
Research

Antecedent Treatment with Different Antibiotic Agents as a Risk Factor for Vancomycin-Resistant Enterococcus

Yehuda Carmeli*†Comments to Author , George M. Eliopoulos*†, and Matthew H. Samore*†
Author affiliations: *Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; †Harvard Medical School, Boston, Massachusetts, USA;

Main Article

Table 2

Multivariable explanatory model for having vancomycin-resistant enterococci-positive case

Variable Odds ratio (95% CI) p value
Main admitting disorder 0.44 (0.28 to 0.68) <0.001
Cardiovascular 2.9 (1.5 to 5.7) 0.002
Infectious
Coexisting conditions
Diabetes mellitus 2.1 (1.5 to 3.1) <0.001
Transplant recipient 2.6 (1.6 to 4.5) <0.001
Hepatobiliary disease 2.9 (1.8 to 4.6) <0.001
MRSA (in past yr)
Clostridium difficile (in past yr) 3.5 (1.8 to 6.9)
2.0 (0.97 to 4.3) <0.001
0.06

CI, confidence interval; MRSA, methicillin-resistant Staphylococcus aureus.

Main Article

Page created: July 16, 2010
Page updated: July 16, 2010
Page reviewed: July 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external